How a Risk Based Approach to Continuous Processing Will Change the Face of the Pharmaceutical Industry (or the Manufacturing Revolution)

The article considers the opportunities for risk based change in facility design through quality by design (QbD) and advances in PAT. It suggests that the approach has relevance equally to biopharm and more traditional oral solid dose products based on a manufacturing “dancefloor” concept (see f...

To read the full article and other articles in this issue, please register for a free account or log in.

We will not sell or give your information to a third party. See our Privacy Policy



Subscribe to our FREE newsletter

We will not sell or give your information to a third party. See our Privacy Policy